Financials

News Discussions Technicals Forecast Seasonals

MLC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Malin Corp. Plc. invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. Its priority assets includes Poseida, Immunocore, Kymab and Viamet. The company was founded on December 16, 2014 and is headquartered in Dublin, Ireland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

MLC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company